Atypical MPNs: focus on CNL and CEL

7 Views
administrator
administrator
07/06/23

Andreas Reiter, MD, University Medical Centre, Mannheim, Germany, gives an overview of the atypical myeloproliferative neoplasms (MPNs), with a focus on chronic neutrophilic leukemia (CNL) and chronic eosinophilic leukemia (CEL). This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.

Show more
0 Comments Sort By

    No comments found

    Facebook Comments

    Up next

    EuroBloodNet's Topic on focus: Cutaneous Lymphoma - Mycosis Fungoides
    00:46:55
    EuroBloodNet's Topic on focus: Cutaneous Lymphoma - Mycosis Fungoides
    administrator
    1 Views
    EuroBloodNet's Topic on focus: Cutaneous Lymphoma - Introduction to CL
    00:44:17
    EuroBloodNet's Topic on focus: Cutaneous Lymphoma - Introduction to CL
    administrator
    2 Views
    EuroBloodNet's Topic on focus: Cutaneous Lymphoma -Aggressive T-cell lymphomas
    01:04:58
    EuroBloodNet's Topic on focus: Cutaneous Lymphoma -Aggressive T-cell lymphomas
    administrator
    3 Views
    Focus on Tumor and Pseudotumor - OCAD/SRad-RJ MSK Case Presentation Series
    00:46:12
    Focus on Tumor and Pseudotumor - OCAD/SRad-RJ MSK Case Presentation Series
    administrator
    2 Views
    Ocular melanoma MDT discuss FOCUS trial and NICE 2021 guidance.
    00:04:20
    Ocular melanoma MDT discuss FOCUS trial and NICE 2021 guidance.
    administrator
    9 Views
    Ocular melanoma MDT discuss FOCUS trial and NICE 2021 guidance.
    00:04:20
    Ocular melanoma MDT discuss FOCUS trial and NICE 2021 guidance.
    administrator
    3 Views
    Individualizing patient care in CML and MPNs
    00:03:35
    Individualizing patient care in CML and MPNs
    administrator
    2 Views
    Myeloid neoplasms - AML, MDS, CML, MPNs
    00:39:53
    Myeloid neoplasms - AML, MDS, CML, MPNs
    administrator
    1 Views
    Using CEC levels to evaluate treatment outcomes of splanchnic vein thrombosis in chronic MPNs
    00:01:23
    Using CEC levels to evaluate treatment outcomes of splanchnic vein thrombosis in chronic MPNs
    administrator
    2 Views
    Webinar: What are MPNs? Everything you need to know 2018
    01:14:24
    Webinar: What are MPNs? Everything you need to know 2018
    administrator
    3 Views
    ESH CML/MPNs 2021: what to expect?
    00:02:05
    ESH CML/MPNs 2021: what to expect?
    administrator
    0 Views
    What to Know When Choosing Among Providers and Treatments for Myeloproliferative Neoplasms (MPNs)
    00:01:22
    What to Know When Choosing Among Providers and Treatments for Myeloproliferative Neoplasms (MPNs)
    administrator
    1 Views
    Finola Hughes: Raising Awareness of Myeloproliferative Neoplasms (MPNs)
    00:01:27
    Finola Hughes: Raising Awareness of Myeloproliferative Neoplasms (MPNs)
    administrator
    2 Views
    Pathology Hematology | 30 | Myeloproliferative neoplasms (MPNs) -6
    00:01:56
    Pathology Hematology | 30 | Myeloproliferative neoplasms (MPNs) -6
    administrator
    4 Views
    Finola Hughes: What She Has Learned by Being an Advocate for Myeloproliferative Neoplasms (MPNs)
    00:00:59
    Finola Hughes: What She Has Learned by Being an Advocate for Myeloproliferative Neoplasms (MPNs)
    administrator
    5 Views
    5 Easy Ways to Raise Your Voice…and Raise Awareness of Myeloproliferative Neoplasms (MPNs)
    00:01:50
    5 Easy Ways to Raise Your Voice…and Raise Awareness of Myeloproliferative Neoplasms (MPNs)
    administrator
    2 Views
    Coronavirus and myeloproliferative neoplasms MPNs - an update
    00:58:18
    Coronavirus and myeloproliferative neoplasms MPNs - an update
    administrator
    4 Views
    Driver mutations in MPNs and their impact on prognosis: JAK2, MPL, and CALR
    00:04:31
    Driver mutations in MPNs and their impact on prognosis: JAK2, MPL, and CALR
    administrator
    2 Views
    Myeloproliferative Neoplasm (MPNs) Update #2 with Dr. Ruben Mesa
    00:13:00
    Myeloproliferative Neoplasm (MPNs) Update #2 with Dr. Ruben Mesa
    administrator
    0 Views